Nephrocare Health Services
NEPHROPLUSNSE

Nephrocare Health Services

₹723.35-13.65 (1.85%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
713.20
Today’s high
745.85
52 week low
446.00
52 week high
769.75
Open price
732.00
Previous close
737.00
Live volume
2,61,481
Lower circuit
578.70
Upper circuit
868.00

Fundamentals

Market Cap
₹7,404Cr
ROE
6.88%
P/E Ratio(TTM)
96.33
EPS(TTM)
7.66
P/B Ratio
6.63
Dividend Yield
0.00%
Industry P/E
60.22
Book Value
111.27
Debt to Equity
0.07
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹277
+5.38%
Profit (Cr)
₹30.37
-5.80%
-75093.75187.5281.3
Dec '24
Mar '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+37%
3Y CAGR+33%
Profit growthValue
1Y (TTM)+51%
3Y CAGR+73%

About

Nephrocare Health Services Limited operates a chain of dialysis centers and provides comprehensive renal care services.;
CEO/MD
Dr. Pratim Sengupta
Founded in
2014
NSE symbol
NEPHROPLUS

Shareholding Pattern

Jul '25
Dec '25
Mar '26
Promoters
63.85%
Foreign Institutions
20.89%
Retail And Others
6.61%
Other Domestic Institutions
5.47%
Mutual Funds
3.17%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,450.00
+5.50 (0.38%)
L
    H
    14,656.0052.068.89
    ₹444.80
    +1.60 (0.36%)
    L
      H
      14,056.6183.676.94
      ₹614.75
      -11.85 (1.89%)
      L
        H
        9,337.36408.767.01
        ₹1,342.00
        +3.70 (0.28%)
        L
          H
          8,795.6845.295.7
          Livesquawk
          Nephrocare Health Services unit signs asset transfer deal with Inocentes Dialysis Clinic.
          Livesquawk
          Nephrocare Health Services to invest up to ₹100M in its Nepal operations. The investment aims to support expansion and operations in Nepal.
          Livesquawk
          Nephrocare Health Q4 EBITDA rises to ₹537M from ₹513M YoY. EBITDA margin declines to 20.2% from 23.4% YoY.
          2026
          19
          May
          Quarterly & Annual Result
          Release date
          10
          Feb
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks